Pyrazolyl quinoxaline kinase inhibitors
US9464071B2 · kind B2 · utility
23Cited by
18References
45Claims
0Family size
Assignee
Inventors
- Gordon Saxty
- Christopher William Murray
- Valerio Berdini
- Gilbert Ebai Besong
- Christopher Charles Frederick Hamlett
- Christopher Norbert Johnson
- Steven John Woodhead
- Michael Reader
- David Charles Rees
- Laurence Anne Mevellec
- Patrick René Angibaud
- Eddy Jean Edgard Freyne
- Tom Cornelis Hortense Govaerts
- Johan Erwin Edmond Weerts
- Timothy Pietro Suren Perera
- Ronaldus Arnodus Hendrika Joseph Gilissen
- Berthold Wroblowski
- Jean Fernand Armand Lacrampe
- Alexandra Papanikos
- Olivier Alexis Georges Querolle
- Elisabeth Therese Jeanne Pasquier
- Isabelle Noëlle Constance Pilatte
- Pascal Bonnet
- Werner Constant Johan Embrechts
- Rhalid Akkari
- Lieven Meerpoel
Key dates
| Filing date | Oct 2, 2014 |
| Grant date | Oct 11, 2016 |
| Priority date | — |
| Expiry date | Oct 2, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/6524
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to new quinoxaline derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.